Previous 10 | Next 10 |
2023-11-09 09:04:59 ET Summary Aldeyra Therapeutics is a strong sell as bearish developments have been met with silence from the management team, amplifying the uncertainty surrounding the future. The company is facing challenges in its journey to become a commercial biotech compa...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
Aldeyra Therapeutics Inc. (ALDX) is expected to report $-0.27 for Q3 2023
2023-11-07 14:12:53 ET If you’re looking for penny stocks to invest in right now, you’ve got your work cut out for you. That’s because the initial strategy when approaching cheap stocks is to trade them in the short term instead of holding them forever. Ther...
2023-11-01 14:11:42 ET Penny stocks are the wild west of the stock market. Fast-paced, unpredictable, and laden with potential treasures. And in this vast landscape, one metric stands out: volume. It’s like the heartbeat of a stock, echoing its vitality and momentum. Today, we...
2023-11-01 13:38:15 ET Gainers: Patriot Transportation Holding ( PATI ) +103% . Aldeyra Therapeutics ( ALDX ) +50% . Davis Commodities Ltd. ( DTCK ) +33% . TG Therapeutics ( TGTX ) +32% . Silence Therapeutics ( SLN ) +31% . S...
2023-11-01 12:08:13 ET DENVER, Colo., Nov. 1, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Aldeyra Therapeutics Inc (NASDAQ: ALDX), Cellectis SA (NASDAQ: CLLS), TG Therapeutics, Inc. (NASDAQ: TG...
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) is one today's most active stocks by volume. So far today, approximately 731.63k shares of Aldeyra Therapeutics, Inc. have been exchanged, as compared to an average 30-day volume of 2.26M shares. Aldeyra Therapeutics, Inc., a biotechnology company, dev...
2023-11-01 09:58:41 ET DENVER, Colo., Nov. 1, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Cellectis SA (NASDAQ: CLLS), TG Therapeutics, Inc. (NASDAQ: TGTX), Monopar Therapeutics Inc. (NASDAQ: MNPR), A...
2023-11-01 08:17:45 ET More on AbbVie, Aldeyra Therapeutics, etc. AbbVie Stock Still A Hold Despite Positive Third Quarter 2023 Results AbbVie Inc. (ABBV) Q3 2023 Earnings Call Transcript AbbVie Q3 Earnings Preview: Tough Comparison For Humira Shouldn't Derail Growth...
News, Short Squeeze, Breakout and More Instantly...
Aldeyra Therapeutics Inc. Company Name:
ALDX Stock Symbol:
NASDAQ Market:
Aldeyra Therapeutics Inc. Website:
Live Webcast Scheduled to Begin at 8:00 a.m. ET Today Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced advancement of new ...
Clinical Trial Results and Potential New Drug Application Resubmission Expected in the Second Half of 2024 Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabo...
Event Scheduled for Thursday, June 20 at 8:00 a.m. ET Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that the company will h...